Probiotic prophylaxis in predicted severe acute pancreatitis

The Lancet

Volumn 372, Issue 9633, 2008, Pages 114-115

  Bjarnason, Alexander ^a   Adler, Samuel N ^b   Bjarnason, Ingvar ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b BIKUR CHOLIM HOSPITAL   (Israel)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROBIOTIC AGENT;

ACUTE PANCREATITIS; DISEASE SEVERITY; ENTEROPATHY; HUMAN; INTESTINE FLORA; INTESTINE ISCHEMIA; INTESTINE MUCOSA PERMEABILITY; LETTER; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; ACUTE DISEASE; INTESTINE; ISCHEMIA; METABOLISM; MICROBIOLOGY; NOTE; PANCREATITIS; PERMEABILITY;

ACUTE DISEASE; HUMANS; INTESTINES; ISCHEMIA; PANCREATITIS; PERMEABILITY; PROBIOTICS;

EID: 46749089207     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61028-4     Document Type: Letter

References (5)

1. Besselink M., van Santvoort H., Buskens E., et al., for the Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 371 (2008) 651-659
2. Bjarnason I., Takeuchi K., Bjarnason A., Adler S., and Teahon K. The G.U.T. of gut. Scand J Gastroenterol 39 (2004) 807-815
3. Bjarnason I., Hayllar J., Macpherson A., and Russell A. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine. Gastroenterology 104 (1993) 1832-1847
4. Bjarnason I., Hayllar J., Smethurst P., Price A., Menzies I., and Gumpel M. Metronidazole reduces inflammation and blood loss in NSAID enteropathy. Gut 33 (1992) 1204-1208
5. Ammori B. Role of the gut in the course of severe acute pancreatitis. Pancreas 26 (2003) 122-129